Katie Quinn

Get more out of your business.

Reach it with Microsoft Dynamics 365 Business Central.

July 23, 2019 Katie Quinn

Senate Finance Provision Increasing ASP for Biosimilars Could Unlock Billions in Savings for Patients and Taxpayers

July 11, 2019 Katie Quinn

New Analysis Confirms Increased Use of Biosimilars Can Save U.S. Up to $71 Billion Over a Decade

June 20, 2019 Katie Quinn

Health Experts Agree Increasing Biosimilar Use Can Help Reduce Rising Drug Costs for Patients

May 29, 2019 Katie Quinn

Biosimilars Forum Announces Support for Policies that Would Save Taxpayers and Seniors Billions

May 23, 2019 Katie Quinn

The Biosimilars Forum Commends Senate HELP Committee’s Effort to Educate Patients and Providers on Biosimilars

March 19, 2019 Katie Quinn

Significant Healthcare Savings Possible if U.S. Cultivates a Robust Biosimilars Market

March 7, 2019 Katie Quinn

The Biosimilars Forum Disagrees with the Food and Drug Administration’s Decision on Naming of Biologic Medicines

March 6, 2019 Katie Quinn

The Biosimilars Forum Recognizes Commissioner Gottlieb’s Leadership Supporting a Strong Biosimilars Market in the U.S.

February 26, 2019 Katie Quinn

Removing 340B Pass-Through Would be Detrimental to US Healthcare Savings

February 26, 2019 Katie Quinn

The Biosimilars Forum Urges Senate Finance Committee to Seek Meaningful Biosimilars Reform